Lapatinib Terminated Phase 2 Trials for Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00881621Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer